Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Investigation of immune and CNS-mediated effects of fingolimod in the focal delayed-type hypersensitivity multiple sclerosis model.
Decreased serum vitamin D levels in Japanese patients with multiple sclerosis.
Changes in brain atrophy indices in patients with relapsing-remitting multiple sclerosis treated with natalizumab.
Considerations on the appropriateness of the John Cunningham virus antibody assay use in patients with rheumatoid arthritis.
2-Methoxyestradiol, an Endogenous 17β-Estradiol Metabolite, Inhibits Microglial Proliferation and Activation via an Estrogen Receptor-Independent Mechanism.
Therapeutic Apheresis in Pediatric Patients with Acute CNS Inflammatory Demyelinating Disease.
Changes of Cine Cerebrospinal Fluid Dynamics in Patients with Multiple Sclerosis Treated with Percutaneous Transluminal Angioplasty: Case-control Study.
Pediatric familial neuromyelitis optica in two sisters with long term follow-up.
Technical developments of functional electrical stimulation to correct drop foot: Sensing, actuation and control strategies.
OnabotulinumtoxinA is Effective in Patients with Urinary Incontinence due to Neurogenic Detrusor Activity Regardless of Concomitant Anticholinergic Use or Neurologic Etiology.
Principles of DNA-Based Gut Microbiota Assessment and Therapeutic Efficacy of Fecal Microbiota Transplantation in Gastrointestinal Diseases.
Complement-dependent pathogenicity of brain-specific antibodies in cerebrospinal fluid.
Regulatory T and B lymphocytes in a spontaneous autoimmune polyneuropathy.
Primary progressive multiple sclerosis: progress and challenges.
Efficacy of the ANAM General Neuropsychological Screening battery (ANAM GNS) for Detecting Neurocognitive Impairment in a Mixed Clinical Sample.
Lower urinary tract symptoms associated with neurological conditions: Observations on a clinical sample of outpatients neurorehabilitation service.
Epidemiological, humanistic, and economic burden of illness of lower limb spasticity in adults: a systematic review.
EBV & HHV6 reactivation is infrequent and not associated with MS clinical course.
Complement receptor 2 is up regulated in the spinal cord following nerve root injury and modulates the spinal cord response.
[A DTI study of the spinal cord lesion in patients with multiple sclerosis during the follow-up after relapse].
Low sensitivity to glucocorticoid inhibition of in vitro Th17-related cytokine production in multiple sclerosis patients is related to elevated plasma lipopolysaccharide levels.
Targeting Central Nervous System B Cells in Progression of Multiple Sclerosis: Is Intrathecal Anti-CD20 a Therapeutic Option?
Current management of relapsing-remitting multiple sclerosis.
[Brain metabolism in multiple sclerosis: effects of neurotrophic therapy.]
Multiple sclerosis: Creating a STIR-MRI sequence improves detection of spinal cord lesions.
Pages
« first
‹ previous
…
456
457
458
459
460
461
462
463
464
…
next ›
last »